Anika Therapeutics Inc (NAS:ANIK)
$ 16.9601 0.6601 (4.05%) Market Cap: 248.39 Mil Enterprise Value: 201.25 Mil PE Ratio: 0 PB Ratio: 1.39 GF Score: 80/100

Q4 2023 Anika Therapeutics Inc Earnings Call Transcript

Mar 13, 2024 / 09:00PM GMT
Release Date Price: $25.4 (-1.51%)
Operator

And yes, yes, good evening, ladies and gentlemen, and welcome to Anika's Fourth Quarter and Year End 2023 earnings conference call. At this time, all lines are in a listen only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call, the required immediate assistance, please press star zero for the operator. I will now turn the call over to Mark Namaroff, Vice President, Investor Relations, ESG and corporate communications. Please proceed.

Mark Namaroff Anika Therapeutics
Inc. - Executive Director of IR & Corporate Communications

Thank you, and good afternoon, everyone. Thank you for joining us for Anika's Fourth Quarter and Year End 2023 Conference Call and Webcast. Our earnings press release was issued after the close of the market today and is available on our Investor Relations website located located at www.Anika.com as our supplementary PowerPoint slides that will be used for discussion today. With me on the call today are Dr. Cheryl

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot